Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomized trial

Depierre, A. ; Chastang, Cl ; Quoix, E. ; Lebeau, B. ; Blachon, F. ; Paillot, N. ; Lemarie, E. ; Milleron, B. ; Moro, D. ; Clavier, J. ; Herman, D. ; Tuchais, E ; Jacoulet, P. ; Brechot, J. M ; Cordier, J. F. ; Solal-Celigny, p. ; Badri, N. ; Besenval, M.

Oxford: Oxford University Press

Texto completo disponível

The efficacy of a combination of ondansetron, methylprednisolone and metopimazine in patients previously uncontrolled with a dual antiemetic treatment in cisplatin-based chemotherapy

LEBEAU, B ; DEPIERRE, A ; GIOVANNINI, M ; RIVIERE, A ; KALUZINSKI, L ; VOTAN, B ; HEDOUIN, M ; D'ALLENS, H

Oxford: Oxford University Press

Texto completo disponível

Long-term survivors of small-cell lung cancer (SCLC): a French multicenter study. Groupe d'Oncologie de Langue Française

Jacoulet, P ; Depierre, A ; Moro, D ; Rivière, A ; Milleron, B ; Quoix, E ; Ranfaing, E ; Anthoine, D ; Lafitte, J J ; Lebeau, B ; Kleisbauer, J P ; Massin, F ; Fournel, P ; Zaegel, M ; Leclerc, J P ; Garnier, G ; Brambilla, E ; Capron, F

England

Texto completo disponível

Long-term survivors of small-cell lung cancer (SCLC): A French multicenter study

Jacoulet, P. ; Depierre, A. ; Moro, D. ; Rivière, A. ; Milleron, B. ; Quoix, E. ; Ranfaing, E. ; Anthoine, D. ; Lafitte, J. J. ; Lebeau, B. ; Kleisbauer, J. P. ; Massin, F. ; Fournel, P. ; Zaegel, M. ; Leclerc, J. P. ; Garnier, G. ; Brambilla, E. ; Capron, F.

Oxford: Oxford University Press

Texto completo disponível

Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy for non-small-cell lung cancer

Quoix, E. ; Lebeau, B. ; Depierre, A. ; Ducolone, A. ; Moro-Sibilot, D. ; Milleron, B. ; Breton, J. L. ; Lemarie, E. ; Pujol, J. L. ; Brechot, J. M. ; Zalcman, G. ; Debieuvre, D. ; Vaylet, F. ; Vergnenegre, A. ; Clouet, P.

Oxford: Oxford University Press

Texto completo disponível

Buprenorphine-induced acute respiratory depression during ifosfamide-based chemotherapy

Moro, C ; Taino, R ; Mandalà, M ; Labianca, R

England: Oxford University Press

Texto completo disponível

What is the real benefit of adjuvant chemotherapy in the Adjuvant Navelbine International Trialist Association trial?

Mandalà, M. ; Moro, C. ; Michetti, G. ; Ferretti, G. ; Labianca, R.

England: Elsevier Ltd

Texto completo disponível

Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial

Mandalà, M. ; Barni, S. ; Prins, M. ; Labianca, R. ; Tondini, C. ; Russo, L. ; Milesi, A. ; Cremonesi, M. ; Zaccanelli, M. ; Regonesi, C. ; Moro, C. ; Falanga, A.

England: Elsevier Ltd

Texto completo disponível

Lung Cancer Harboring Her2 Mutation: Epidemiological Characteristics and Therapeutic Perspectives

Mazieres, J. ; Peters, S. ; Cortot, A. ; Besse, B. ; Barlesi, F. ; Beau-Faller, M. ; Urban, T. ; Moro-Sibilot, D. ; Milia, J. ; Gautschi, O.

Texto completo disponível

Phase II Study of Bevacizumab in Combination with 1st-Line Chemotherapy or 2nd-Line Erlotinib in Non-Squamous Nsclc (Ns-Nsclc) Patients with Asymptomatic Untreated Brain Metastases (ML21823)

Besse, B. ; Le Moulec, S. ; Senellart, H. ; Mazieres, J. ; Barlesi, F. ; Dansin, E. ; Robinot, G. ; Perol, M. ; Moro-Sibilot, D. ; Soria, J.

Texto completo disponível